Quick Answer
MoCRA deadlines 2026 are led by the first cosmetics biennial renewal in July 2026. Facilities that registered under the initial MoCRA deadlines must renew their registration during the renewal window or risk losing their active status with FDA. Other key deadlines include ongoing adverse event reporting (15 business days) and preparation for upcoming GMP rules. Note: the proposed asbestos testing rule was withdrawn by FDA on November 28, 2025, and small business exemptions (under $1M annual sales) expired in December 2025.
What Are the Key MoCRA Deadlines?
Foreign Facility
Raw Data InputTranslation Layer
Validation ActiveFDA FURLS
Live SyncCompliance Vault
ImmutableThe Modernization of Cosmetics Regulation Act (MoCRA) established a phased rollout of requirements that began in late 2023 and extends into 2026 and beyond. Understanding the full timeline is critical for maintaining compliance and avoiding enforcement actions. For a complete overview of all MoCRA obligations, see our MoCRA compliance guide.
Below is the complete MoCRA deadline timeline, showing what has already passed, what is coming up, and what remains to be determined.
MoCRA Deadline Timeline
Completed
July 2024
Facility registration required. All cosmetics manufacturing and processing facilities must be registered with FDA per FD&C Act Section 607 (as amended by MoCRA).
December 2024
Product listing required. All cosmetic products marketed in the US must be listed with FDA. Small business exemptions (under $1M annual sales) also expired in December 2025.
March 2025
Adverse event reporting required. Serious adverse events must be reported to FDA within 15 business days.
July 2025
Safety substantiation required. Responsible persons must have adequate evidence of product safety available for FDA inspection.
November 28, 2025
Asbestos testing proposed rule withdrawn by FDA. The previously proposed March 2026 asbestos testing deadline no longer applies.
Upcoming
July 2026 Action Required
First cosmetics biennial facility registration renewal. All registered facilities must renew or lose active status.
To Be Determined
GMP Final Rule
FDA is still developing the Good Manufacturing Practice final rule. Date TBD -- no NPRM has been published yet. Companies should prepare now by aligning with ISO 22716.
Fragrance Allergen Labeling Proposed Rule
FDA NPRM (Notice of Proposed Rulemaking) anticipated around May 2026. This is a proposed rule, not a compliance deadline. Once finalized, companies will have a compliance period to update labels. Expected to align with EU's 26 allergen disclosure requirement.
When Must Facilities Register?
Foreign Supplier
HACCP Plan Required
Assurentry FSVP Engine
FDA Systems
Audit Ready Records
Under FD&C Act Section 607 (as amended by MoCRA), cosmetics facility registration has been required since July 2024. FDA provided an extended compliance period through late 2024 for initial registrations.
Deadline Passed
The initial facility registration deadline has passed. If your facility is already registered, your next action is the biennial renewal in July 2026. If you have not yet registered, you should do so immediately -- new facilities must register before beginning to manufacture cosmetics for the US market.
Who Must Register?
- All facilities that manufacture or process cosmetics distributed in the US
- Contract manufacturers making cosmetics for other companies
- Foreign facilities exporting cosmetics to the United States
New Facilities
Any facility that begins manufacturing cosmetics after the initial deadline must register before commencing manufacturing operations. There is no grace period for new entrants -- registration must be completed through FDA's Cosmetics Direct portal prior to production. Our step-by-step MoCRA registration guide walks you through the process.
When Is the Product Listing Deadline?
Product listing requirements have been in effect since December 2024. This requirement is now fully in effect and is an ongoing obligation under FD&C Act Section 607 (as amended by MoCRA).
Already Effective
Product listing is a current, ongoing obligation. All cosmetic products marketed in the US must be listed with FDA. New products must be listed before entering the market, and changes to existing listings must be updated within 60 days.
What Must Be Listed?
- Every cosmetic product distributed in the United States
- Products manufactured domestically and those imported from abroad
- Private label and contract-manufactured products
- Products sold through professional and retail channels
Ongoing Obligations
Product listings are not a one-time filing. You must update your listings within 60 days when a product is discontinued, its formulation significantly changes, or a new product is introduced. Failure to maintain current listings can trigger FDA enforcement.
What Is the Biennial Renewal Schedule?
FDA Observation
"Procedures for verifying supplier controls were not adequately established."
CAPA Deployed
Assurentry auto-generates a 15-day response plan with acceptable corrective actions.
The biennial renewal is the most critical upcoming MoCRA deadline in 2026. Unlike food facility registration, which renews in even-numbered years, cosmetics facility registration follows its own biennial cycle.
Urgent: July 2026 Biennial Renewal
The first cosmetics biennial registration renewal is expected in July 2026. Facilities that registered in 2023 or 2024 must renew during this window. Missing the renewal means your facility registration lapses, potentially halting your ability to legally manufacture and distribute cosmetics in the US.
What You Need to Know
- Renewal window: FDA will open the renewal period approximately two years after initial registration became effective
- Process: Renewal is completed through FDA's Cosmetics Direct portal
- Updates required: You must verify and update all facility information, product categories, and brand names during renewal
- No fee: Registration renewal is free through FDA's electronic system
Consequences of Missing Renewal
If you fail to renew by the deadline, your facility registration will lapse. This means:
- Your facility will no longer appear as registered in FDA's database
- Products manufactured at the facility may be considered adulterated
- Import shipments from unregistered foreign facilities could be refused entry
- FDA may consider the lapse during any future inspection or enforcement action
July 2026 renewal deadline approaching
The first biennial MoCRA facility registration renewal is due July 2026. Assurentry automates the renewal process — set up once and we handle the filing, reminders, and confirmation automatically.
Start automated MoCRA workflow →When Do Adverse Event Reporting Rules Apply?
Automated Extraction
Our systems parse complex FDA documents into actionable data instantly.
Mandatory serious adverse event (SAE) reporting has been required since March 2025. This is an ongoing obligation with no future deadline -- it applies every time a serious adverse event is reported to a responsible person.
Ongoing Requirement
You must report serious adverse events to FDA within 15 business days of receiving the report. This applies to all cosmetics companies regardless of size -- there is no small business exemption for adverse event reporting.
What Qualifies as a Serious Adverse Event?
- Death or life-threatening experience
- Inpatient hospitalization
- Persistent or significant disability or incapacity
- Congenital anomaly or birth defect
- Significant disfigurement (including serious rash, burns, hair loss, or persistent skin discoloration)
- Medical or surgical intervention to prevent any of the above
Reporting Process
Reports must be submitted to FDA via the CFSAN Adverse Event Reporting System (CAERS). You must include product identification, a description of the adverse event, and contact information for the reporter. Follow-up information must be submitted within one year if new safety data becomes available.
Record Retention
All adverse event records -- including non-serious events -- must be maintained for 6 years and be available for FDA inspection upon request.
When Will GMP Rules Take Effect?
MoCRA requires cosmetics to be manufactured in accordance with Good Manufacturing Practice (GMP). However, FDA has not yet published a final GMP rule or Notice of Proposed Rulemaking (NPRM). The effective date remains To Be Determined (TBD).
Prepare Now, Even Without a Final Date
The GMP final rule date is TBD and no NPRM has been published. However, FDA has signaled that compliance with ISO 22716 (Cosmetics GMP) will likely satisfy the requirement. Companies should begin aligning their manufacturing processes now rather than waiting for the final rule.
What to Prepare
Even without a final GMP rule, you should be implementing these practices:
- Personnel: Training programs, hygiene protocols, and qualification records
- Facilities: Proper design, maintenance schedules, and sanitation procedures
- Equipment: Calibration, cleaning validation, and maintenance logs
- Raw materials: Supplier qualification, incoming testing, and storage controls
- Production: Batch records, in-process controls, and packaging validation
- Quality control: Finished product testing, specifications, and release procedures
- Documentation: SOPs, change control, and deviation management
What About Fragrance Allergen Disclosure?
MoCRA mandates that specific fragrance allergens be disclosed on product labels. However, FDA must first finalize the list of allergens that require disclosure. An FDA NPRM (Notice of Proposed Rulemaking) is anticipated around May 2026. This is a proposed rule -- not a compliance deadline. Once a final rule is published, companies will have a compliance period to update their labels.
What We Know
- FDA's allergen list is expected to closely mirror the EU's 26 fragrance allergens that require disclosure above certain concentration thresholds
- The NPRM is anticipated around May 2026; after public comment and finalization, there will be a compliance period (likely 1-2 years) for companies to update their labels
- The requirement applies to both leave-on and rinse-off cosmetics
How to Prepare
Even without the final list, proactive companies should take these steps now:
- Audit your fragrance formulations for known EU-regulated allergens
- Request allergen declarations from fragrance suppliers
- Assess label real estate -- you may need more space for allergen disclosures
- Begin planning label redesigns to accommodate the new requirements
What Are the Penalties for Missing Deadlines?
MoCRA gives FDA significant new enforcement authority over cosmetics. Failing to meet deadlines can result in consequences ranging from warning letters to product seizures.
Enforcement Risks
Under MoCRA, cosmetics that do not comply with registration, listing, labeling, or GMP requirements may be deemed adulterated or misbranded -- giving FDA the authority to take enforcement action including product detention, seizure, or injunction.
Potential Consequences
Warning Letters
FDA can issue warning letters for non-compliance, which become public record and can damage your brand reputation.
Import Detention
Products from unregistered foreign facilities may be refused entry at the border, causing shipment delays and financial losses.
Product Seizure
FDA can seize adulterated or misbranded cosmetics from the marketplace, resulting in lost inventory and legal costs.
Mandatory Recall
MoCRA grants FDA mandatory recall authority for cosmetics -- a power the agency did not have before this law.
How Can I Prepare for Upcoming Deadlines?
Staying ahead of MoCRA deadlines requires a structured approach. Use this checklist to ensure you are ready for every requirement.
MoCRA 2026 Preparation Checklist
Pro Tip: Start Your Biennial Renewal Early
Do not wait until the renewal window opens. Begin gathering updated facility information, verifying product categories, and confirming brand names now. This way, you can complete the renewal as soon as FDA opens the window and avoid any last-minute technical issues with the Cosmetics Direct portal.
How Does Assurentry Help with MoCRA Compliance?
MoCRA introduced the most sweeping changes to US cosmetics regulation in over 80 years. Keeping track of every deadline, maintaining registration status, filing product listings, and managing adverse event reporting is a substantial operational burden -- especially for companies managing multiple facilities or large product portfolios.
Registration Management
We handle initial registration, biennial renewals, and facility updates through FDA's Cosmetics Direct portal on your behalf.
Product Listing
Complete product listing management including initial filings, updates, and discontinuation tracking across your entire portfolio.
Deadline Tracking
Automated alerts for biennial renewals, AE reporting windows, and upcoming regulatory changes so you never miss a deadline.
GMP Readiness
SOP templates, gap analysis, and ISO 22716 alignment support to prepare your manufacturing operations before the GMP rule is finalized.
Stop reading. Start executing.
Assurentry acts as a technical translation layer. You provide basic business info, and we automatically generate and file the exact electronic submissions required by the FDA.
Automate compliance100% FDA Acceptance Guaranteed